OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2017
(3)
2022
(2)
2021
(2)
2020
(2)
2019
(2)
2023
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Screening for Distress in Oncological Patients: The Revised Version of the Psychological Distress Inventory (PDI-R).
Not available
S-EPMC9121122
|
biostudies-literature
Cite
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
Not available
S-EPMC5709672
|
biostudies-literature
Cite
Psychosocial Impact of Virtual Cancer Care through Technology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Not available
S-EPMC10093026
|
biostudies-literature
Cite
Effectiveness of a Psychosocial Care Quality Improvement Strategy to Address Quality of Life in Patients With Cancer: The HuCare2 Stepped-Wedge Cluster Randomized Trial.
Not available
S-EPMC8517739
|
biostudies-literature
Cite
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
Not available
S-EPMC5733132
|
biostudies-literature
Cite
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Not available
S-EPMC6687727
|
biostudies-literature
Cite
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Not available
S-EPMC4220280
|
biostudies-literature
Cite
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial.
Not available
S-EPMC7373944
|
biostudies-literature
Cite
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Not available
S-EPMC6440108
|
biostudies-literature
Cite
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Not available
S-EPMC7649863
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets